Business Wire

PA-PMI

8.2.2021 20:06:03 CET | Business Wire | Press release

Share
Project Management Institute’s Megatrends 2021 Underscores How Projects Will Counterbalance the Rising Forces of Disruption

Project Management Institute (PMI) has released its latest report on long-term business, geopolitical, and technological trends that are reshaping our world and the types of projects that will be most prevalent and critical in the years to come in the face of these disruptions. Megatrends 2021 helps to ensure that project leaders can better understand the world’s rapid transformation and the global context in which they are working today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210208005744/en/

“We know the world changed significantly in 2020, but our research confirmed the long-term impact of how these trends are changing how the world does business,” said Sunil Prashara, President and CEO of Project Management Institute. “There is virtually no industry and no geography that is untouched by the five megatrends outlined in this report. From COVID-19 to the climate crisis to the mainstream use of AI, these forces are driving change across sectors, requiring leaders to embrace new ways of thinking and working. As change-makers in their organizations and communities, project leaders are in a unique position to tackle these challenges and embrace new possibilities.”

The report, which draws on trend data, secondary research, and interviews with project professionals, news reports, and industry data, elaborates on a range of cross-cutting and urgent themes:

  • The impact of COVID-19 revealed deep vulnerabilities in our technology preparedness capabilities and deep-seated inequities in our health, education, and economic systems.
  • The climate crisis is compelling leaders in every sector to collaborate and marshal resources on a global scale to alter the broad trajectory of climate change and mitigate its many near-term consequences.
  • The global wave of protests spanning the past decade has revealed that change is not a question of if, but rather when, and has sparked a growing corporate commitment to racial, gender and ethnic diversity.
  • Emerging markets hold the promise of addressing long-festering challenges like global poverty, as well as the potential to reap the demographic dividend, but still require significant global investments in infrastructure and education.
  • The growth of artificial intelligence (AI) has rewired the possibilities for technology and continued learning, but leaders must grapple with the ethical implications of AI on the complex issues of bias and inequality.

These complex challenges will continue to drive demand for versatile and bold project talent who can help make social impact projects a strategic priority, foster open and innovative partnership ecosystems, and rethink relationships with customers and wider stakeholders.

Project-based skills are essential to helping enterprises turn ideas into a reality. The capabilities of project professionals and change-makers with a broad global perspective will only grow in The Project Economy , the emerging global landscape in which organizations will increasingly deliver financial and societal value through the successful completion of projects, delivery of products, and alignment to value streams.

“We live in a world of change and uncertainty—and COVID-19 has accelerated these trends with major shocks and disruptions to the world of business and society itself overnight,” said Prashara. “This report provides a preview of the world we’ll live in and how our community of project professionals and change-makers can drive greater social impact and value, no matter what sector or corner of the world. Success today requires that they continue to cultivate a strong business acumen and understanding of the broader strategic environment in which we’re operating.”

You can read the full Megatrends 2021 report online at https://www.pmi.org/learning/thought-leadership/megatrends .

About Project Management Institute (PMI)

Project Management Institute (PMI) is the world's leading association for those who consider project, program or portfolio management their profession. Through global advocacy, collaboration, education and research, we work to prepare more than three million professionals around the world for The Project Economy: the coming economy in which work, and individuals, are organized around projects, products, programs and value streams. Now 50 years in the making, we work in nearly every country around the world to advance careers, improve organizational success and further mature the project management profession through globally-recognized standards, certifications, communities, resources, tools, academic research, publications, professional development courses and networking opportunities. As part of the PMI family, ProjectManagement.com® interactive website creates online global communities that deliver more resources, better tools, larger networks and broader perspectives. Visit us at www.PMI.org , www.projectmanagement.com , www.facebook.com/PMInstitute and on Twitter @PMInstitute .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye